Free Trial

Jasper Therapeutics (JSPR) Short Interest Ratio & Short Volume

Jasper Therapeutics logo
$3.97 +0.05 (+1.28%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$4.14 +0.17 (+4.28%)
As of 04/17/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Jasper Therapeutics Short Interest Data

Jasper Therapeutics (JSPR) has a short interest of 1.87 million shares, representing 15.74% of the float (the number of shares available for trading by the public). This marks a 11.98% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 284,462 shares to cover all short positions.

Current Short Interest
1,870,000 shares
Previous Short Interest
1,670,000 shares
Change Vs. Previous Month
+11.98%
Dollar Volume Sold Short
$8.04 million
Short Interest Ratio
3.6 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
15,022,000 shares
Float Size
11,880,000 shares
Short Percent of Float
15.74%
Today's Trading Volume
85,807 shares
Average Trading Volume
284,462 shares
Today's Volume Vs. Average
30%
Short Selling Jasper Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Jasper Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JSPR Short Interest Over Time

JSPR Days to Cover Over Time

JSPR Percentage of Float Shorted Over Time

Jasper Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20251,870,000 shares $8.04 million +12.0%15.7%3.6 $4.30
3/15/20251,670,000 shares $9.17 million -19.7%14.1%3.2 $5.49
2/28/20252,080,000 shares $12.33 million -16.8%17.5%4 $5.93
2/15/20252,500,000 shares $15.20 million -8.1%21.1%5 $6.08
1/31/20252,720,000 shares $16.48 million -15.5%24.2%5.7 $6.06
1/15/20253,220,000 shares $18.74 million +38.8%28.7%7.2 $5.82
12/31/20242,320,000 shares $49.60 million +12.1%20.6%5.6 $21.38
12/15/20242,070,000 shares $42.64 million +0.5%18.4%7.7 $20.60
11/30/20242,060,000 shares $46.99 million +6.2%18.3%7.6 $22.81
11/15/20241,940,000 shares $39.63 million +10.2%17.2%7 $20.43
10/31/20241,760,000 shares $37.28 million -2.8%15.2%6.6 $21.18
10/15/20241,810,000 shares $33.09 million +21.5%15.6%7.3 $18.28
9/30/20241,490,000 shares $28.03 million -22.8%12.9%7.3 $18.81
9/15/20241,930,000 shares $43.91 million -3.5%16.7%9.2 $22.75
8/31/20242,000,000 shares $43.60 million +8.7%17.3%10.6 $21.80
8/15/20241,840,000 shares $33.30 million +12.2%16.0%10.4 $18.10
7/31/20241,640,000 shares $30.32 million +40.2%15.0%10.1 $18.49
7/15/20241,170,000 shares $23.31 million +40.6%10.7%8.3 $19.92
6/30/2024832,100 shares $18.89 million +4.3%7.6%7.1 $22.70
6/15/2024798,200 shares $19.97 million +16.6%7.3%9.3 $25.02
5/31/2024684,800 shares $17.78 million +5.1%6.3%7.5 $25.96
5/15/2024651,500 shares $14.07 million +6.0%6.0%6.5 $21.60
4/30/2024614,400 shares $14.67 million +24.8%5.2%5.4 $23.87
4/15/2024492,400 shares $12.95 million +9.0%4.2%4.4 $26.30
3/31/2024451,900 shares $13.27 million +38.1%3.8%3.5 $29.36
3/15/2024327,300 shares $8.21 million +13.3%2.8%2.6 $25.08
2/29/2024288,900 shares $6.14 million +2.5%2.7%2.1 $21.25
2/15/2024282,000 shares $5.06 million +2.1%2.7%2.2 $17.95
1/31/2024276,200 shares $3.25 million +43.5%3.4%2.5 $11.78
1/15/2024192,500 shares $1.62 million +4.5%2.4%2.2 $8.39
12/31/2023184,300 shares $1.45 million -90.4%2.3%3 $7.89
12/15/20231,910,000 shares $924,058.00 +0.5%2.4%3.1 $0.48
11/30/20231,900,000 shares $1.17 million +2.7%2.4%4.8 $0.61
11/15/20231,850,000 shares $1.06 million +1.1%2.3%5.3 $0.57
10/31/20231,830,000 shares $1.21 million -2.7%2.3%5.5 $0.66
10/15/20231,880,000 shares $1.64 million +6.8%2.4%5.7 $0.87
9/30/20231,760,000 shares $1.23 million +45.5%2.2%5.2 $0.70
9/15/20231,210,000 shares $992,200.00 +11.0%1.5%3.7 $0.82
8/31/20231,090,000 shares $1.34 million +9.0%1.4%4.1 $1.23
8/15/2023999,600 shares $1.44 million -1.0%1.3%3.6 $1.44
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
7/31/20231,010,000 shares $1.53 million +19.5%1.3%3.3 $1.51
7/15/2023845,500 shares $1.19 million +3.3%1.1%2.5 $1.41
6/30/2023818,600 shares $1.12 million +13.2%1.0%1.6 $1.37
6/15/2023723,100 shares $1.06 million -16.1%0.9%1.4 $1.47
5/31/2023861,500 shares $1.34 million -18.0%1.1%1.3 $1.55
5/15/20231,050,000 shares $1.64 million -16.7%1.3%1.2 $1.56
4/30/20231,260,000 shares $1.68 million -67.5%1.7%1.2 $1.33
4/15/20233,880,000 shares $5.63 million +5.7%4.8%2.9 $1.45
3/31/20233,670,000 shares $6.64 million +20.7%4.4%1.4 $1.81
3/15/20233,040,000 shares $5.78 million -12.1%3.6%0.8 $1.90
2/28/20233,460,000 shares $6.68 million +46.0%4.1%1 $1.93
2/15/20232,370,000 shares $4.14 million +76.9%2.8%0.7 $1.75
1/31/20231,340,000 shares $2.28 million +52.0%1.6%0.4 $1.70
1/15/2023881,800 shares $1.57 million +240.7%6.9%0.3 $1.78
12/30/2022258,800 shares $124,974.52 +21.6%2.0%0.1 $0.48
12/15/2022212,900 shares $137,022.44 +48.1%1.7%3.2 $0.64
11/30/2022143,800 shares $90,306.40 +30.6%1.2%2.2 $0.63
11/15/2022110,100 shares $71,565.00 +37.6%0.9%1.6 $0.65
10/31/202280,000 shares $58,400.00 +78.6%0.7%1.1 $0.73
10/15/202244,800 shares $32,475.52 -54.2%0.4%0.6 $0.72
9/30/202297,800 shares $77,173.98 +1,170.1%0.7%1.4 $0.79
9/15/20227,700 shares $10,010.00 -89.9%0.1%0.1 $1.30
8/31/202276,400 shares $145,160.00 -25.3%0.6%1.8 $1.90
8/15/2022102,300 shares $214,830.00 -7.3%0.8%2.8 $2.10
7/31/2022110,300 shares $208,467.00 -6.6%0.8%3.2 $1.89
7/15/2022118,100 shares $227,933.00 -9.7%0.9%2.7 $1.93
6/30/2022130,800 shares $252,444.00 +96.4%1.0%3.1 $1.93
6/15/202266,600 shares $133,866.00 -26.6%0.5%1.2 $2.01
5/31/202290,700 shares $287,519.00 -5.6%0.7%1.6 $3.17
5/15/202296,100 shares $287,339.00 -31.8%0.7%1.3 $2.99
4/30/2022140,900 shares $429,745.00 +15.4%1.1%1.7 $3.05
4/15/2022122,100 shares $347,985.00 -6.6%1.0%1.5 $2.85
3/31/2022130,700 shares $463,985.00 -30.6%1.1%1.4 $3.55
3/15/2022188,400 shares $580,272.00 -36.3%1.5%2 $3.08
2/28/2022295,900 shares $1.11 million +3.6%2.4%1.9 $3.75
2/15/2022285,500 shares $1.32 million -36.4%2.3%1.6 $4.63
1/31/2022448,900 shares $2.12 million +2.1%3.6%2.1 $4.73
1/15/2022439,700 shares $2.54 million -10.4%3.5%1.4 $5.77
12/31/2021490,800 shares $3.85 million No Change4.0%0.2 $7.85

JSPR Short Interest - Frequently Asked Questions

What is Jasper Therapeutics' current short interest?

Short interest is the volume of Jasper Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 1,870,000 shares of JSPR short. 15.74% of Jasper Therapeutics' shares are currently sold short. Learn More on Jasper Therapeutics' current short interest.

What is a good short interest ratio for Jasper Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. JSPR shares currently have a short interest ratio of 4.0. Learn More on Jasper Therapeutics's short interest ratio.

Which institutional investors are shorting Jasper Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Jasper Therapeutics: Sphera Funds Management LTD., Millennium Management LLC, Citadel Advisors LLC, 683 Capital Management LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Jasper Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.74% of Jasper Therapeutics' floating shares are currently sold short.

Is Jasper Therapeutics' short interest increasing or decreasing?

Jasper Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 1,870,000 shares, an increase of 12.0% from the previous total of 1,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Jasper Therapeutics' float size?

Jasper Therapeutics currently has issued a total of 15,022,000 shares. Some of Jasper Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Jasper Therapeutics currently has a public float of 11,880,000 shares.

How does Jasper Therapeutics' short interest compare to its competitors?

15.74% of Jasper Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Jasper Therapeutics: Atea Pharmaceuticals, Inc. (4.46%), Aquestive Therapeutics, Inc. (11.93%), Candel Therapeutics, Inc. (12.93%), Aurora Cannabis Inc. (9.02%), Astria Therapeutics, Inc. (6.16%), Compass Therapeutics, Inc. (8.20%), Bright Minds Biosciences Inc. (2.03%), Monopar Therapeutics Inc. (1.32%), Nuvectis Pharma, Inc. (13.46%), Lifecore Biomedical, Inc. (7.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Jasper Therapeutics stock?

Short selling JSPR is an investing strategy that aims to generate trading profit from Jasper Therapeutics as its price is falling. JSPR shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Jasper Therapeutics?

A short squeeze for Jasper Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JSPR, which in turn drives the price of the stock up even further.

How often is Jasper Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JSPR, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:JSPR) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners